Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:794 (12 April), doi:10.1136/bmj.39545.589468.DB
| The first 150 words of the full text of this article appear below. |
Making a difference: How can doctors make the biggest difference to the care of their patients? From a poll of its readers the BMJ drew up a shortlist of six topics in which the BMJ Group will create and compile content across its portfolio of products (the journals, Clinical Evidence, Best Treatments, and BMJ Learning) to improve care. You can see the topics and vote for the one you think should be covered first at bmj.com.
Drug company withdraws advertisement after complaint: The drug company Takeda has agreed to withdraw an advertisement published in January 2008 in Pulse and GP magazines after the Medicines and Healthcare Regulatory Authority ruled it was in breach of their advertising regulations. The advertorial about pioglitazone (Actos) did not reflect the balance of risks and benefits for the product to people with cardiac failure or a history of cardiac failure. Takeda has also
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?